Search
CELL BANK Website

Back Back
RCB0735 : OS-RC-2  update : 2018/07/06
CommentRenal tumor cell from a Japanese. Transplantable to nude mice.
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Kinouchi, Toshiaki
Originator Kinouchi, Toshiaki
Year of deposit 1992
Animal human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Male
Tissue kidney
Case history renal cell carcinoma
Metastastatic ability Yes
Metastatsd tissue lung
Classification cancer
Year of origin 1982
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Virus (HIV) (-)
Isozyme LD, NP
Chromosome mode 68-146(50) : 69(4),70(6),71(10),72(13),73(2),74(3)/
Images
deposit info
lot info
Reference information Reference 1
User's Publication 29


To topTop
Reference
1578  Human renal cell carcinoma: establishment and characterization of a new cell line (OS-RC-2).  Kinouchi T, Kotake T, Mori Y, Abe T  In Vitro Cell Dev Biol  1985  21:195-9  PubMed ID: 4008433

To topTop
User's Publication
2061  [Effect of recombinant human basic fibroblast growth factor (bFGF) on the growth of human tumor cell lines]  Sugimoto H, Nishino H  Hum Cell  1996  9:129-40  PubMed ID: 9183641
2561  Differences in cell kinetic changes among renal cancer cell lines treated with interferon-alpha.  Kasuya Y, Hosaka Y, Matsushima H, Goto T, Kitamura T  Int J Urol  2001  8:449-54  PubMed ID: 11555012
2548  Exip, a new alternative splicing variant of p38 alpha, can induce an earlier onset of apoptosis in HeLa cells.  Sudo, Tatsuhiko, Yagasaki, Yuki, Hama, Hiroshi, Watanabe, Naoko, Osada, Hiroyuki  Biochem Biophys Res Commun  2002  291:838-43  PubMed ID: 11866441
2661  Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1.  Kasuya, Yutaka, Hosaka, Yoshio, Matsushima, Hisashi, Goto, Toshitaka, Kitamura, Tadaichi, Okuyama, Akira  Int J Urol  2003  10:323-31  PubMed ID: 12757604
3344  Significance of COX-2 expression in human renal cell carcinoma cell lines.  Chen, Qinzhong, Shinohara, Nobuo, Abe, Takashige, Watanabe, Takafumi, Nonomura, Katsuya, Koyanagi, Tomohiko  Int J Cancer  2004  108:825-32  PubMed ID: 14712483
3164  The relationship between the branch-forming glycosyltransferases and cell surface sugar chain structures.  Takamatsu, Shinji, Inoue, Noboru, Katsumata, Toshiyuki, Nakamura, Katsumi, Fujibayashi, Yasuhisa, Takeuchi, Makoto  Biochemistry  2005  44:6343-9  PubMed ID: 15835923
3396  Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.  Yamada, Daisuke, Kikuchi, Shinji, Williams, Yuko N, Sakurai-Yageta, Mika, Masuda, Mari, Maruyama, Tomoko, Tomita, Kyoichi, Gutmann, David H, Kakizoe, Tadao, Kitamura, Tadaichi, Kanai, Yae, Murakami, Yoshinori  Int J Cancer  2006  118:916-23  PubMed ID: 16152585
7122  Effects of Cabazitaxel in Renal Cell Carcinoma Cell Lines.  Mizutani K, Tomoda M, Ohno Y, Hayashi H, Fujita Y, Kawakami K, Kameyama K, Kato T, Sugiyama T, Itoh Y, Ito M, Deguchi T.  Anticancer Res.  2015  35:6671-7  PubMed ID: 26637883
7814  Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.  Ito H, Honda K, Satow R, Arai E, Shitashige M, Ono M, Sakuma T, Sakano S, Naito K, Matsuyama H, Yamada T.  Jpn. J. Clin. Oncol.  2011  41:847-53  PubMed ID: 21576114
8278  Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.  Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, Akino T, Kondo T, Miseki T, Nakagawa K, Shindoh M, Harabayashi T, Shinohara N, Nonomura K, Kobayashi M.  Int. J. Oncol.  2010  36:1379-86  PubMed ID: 20428760
8328  Inhibitory effects of cationic hybrid liposomes on the growth of human renal cell carcinoma.  Umebayashi M, Makizono T, Ichihara H, Matsumoto Y, Ueoka R.  Anticancer Res.  2010  30:327-37  PubMed ID: 20332436
8332  Isolated tumor endothelial cells maintain specific character during long-term culture.  Matsuda K, Ohga N, Hida Y, Muraki C, Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, Hida K.  Biochem. Biophys. Res. Commun.  2010  394:947-54  PubMed ID: 20302845
8356  NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.  Hosono T, Tanaka T, Tanji K, Nakatani T, Kamitani T.  Br. J. Cancer  2010  102:873-82  PubMed ID: 20160729
9957  Construction of an aptamer modified liposomal system targeted to tumor endothelial cells.  Ara MN, Matsuda T, Hyodo M, Sakurai Y, Ohga N, Hida K, Harashima H.  Biol. Pharm. Bull.  2014  37:1742-9  PubMed ID: 25366480
10073  C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.  Yue D, Wang Y, Sun Y, Niu Y, Chang C.  Neoplasia  2017  19:135-144  PubMed ID: 28107702
10482  Exosomes expressing carbonic anhydrase 9 promote angiogenesis.  Horie K, Kawakami K, Fujita Y, Sugaya M, Kameyama K, Mizutani K, Deguchi T, Ito M.  Biochem. Biophys. Res. Commun.  2017  492:356-361  PubMed ID: 28851650
10739  Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.  Nishida J, Miyazono K, Ehata S.  Oncogene  2018  37:2197-2212  PubMed ID: 29391598
10839  Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells.  Tsuchida A, Senda M, Ito A, Saito S, Kiso M, Ando T, Harduin-Lepers A, Matsuda A, Furukawa K, Furukawa K.  Sci Rep  2018  8:7017  PubMed ID: 29728594
5012  Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.  Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.  Hum Mol Genet  2006  15(6):821-30  PubMed ID: 16439445
3744  Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.  Nakamura R, Oyama T, Tajiri R, Mizokami A, Namiki M, Nakamoto M, Ooi A.  Cancer Sci  2015  106(5):656-64  PubMed ID: 25726761
3516  Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines.  Takaoka N, Takayama T, Teratani T, Sugiyama T, Mugiya S, Ozono S.  BMC Mol Biol  2011  12:31  PubMed ID: 21771320
5280  Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.  Otsubo T, Hida Y, Ohga N, Sato H, Kai T, Matsuki Y, Takasu H, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Nonomura K, Hida K.  Cancer Sci  2014  105(5):560-7  PubMed ID: 24602018
6080  The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.  Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, Hida K.  Pathol Int  2013  63(1):37-44  PubMed ID: 23356224
6100  CXCR7: a novel tumor endothelial marker in renal cell carcinoma.  Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K.  Pathol Int  2012  62(5):309-17  PubMed ID: 22524658
6126  Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors.  Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M.  Am J Pathol  2009  175(6):2657-67  PubMed ID: 19875502
6174  Clustering of Cancer Cell Lines Using A Promoter- Targeted Liquid Hybridization Capture-Based Bisulfite Sequencing Approach.  Gao F, Wang J, Ji G, Liu S, Yao Y, Wang T, Wu H, Xia Y, Gong D, Jiang H, Yang H, Zhang X.  Technol Cancer Res Treat  2015  14(4):383-94.  PubMed ID: 26269607
6336  Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.  Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C.  Oncotarget  2015  6(31):31203-15  PubMed ID: 26304926
6393  GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma.  Inowa T, Hishikawa K, Matsuzaki Y, Isagawa T, Takeuchi T, Aburatani H, Kitamura T, Fujita T.  Stem Cells Int  2010  2010:782967  PubMed ID: 21048853
2318  High rate of induction of human autologous cytotoxic T lymphocytes against renal carcinoma cells cultured with an interleukin cocktail.  Liu SQ, Kawai K, Shiraiwa H, Hayashi H, Akaza H, Hashizaki K, Shiba R, Saijo K, Ohno T.  Jpn J Cancer Res  1998  89(11):1195-201  PubMed ID: 9914789



Back Back Return Top Page